Anbio Biotechnology
NNNNNASDAQHealthcareMedical Instruments & Supplies
As of Oct 26, 2026 close
- Market cap
- $162.40M
- P/E (TTM)
- 24.22
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.09$44.73
- Volume (live)
- -
- Avg. volume (3M)
- 119.60K
Anbio Biotechnology (NNNN) Stock Price & Financial Analysis
Anbio Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.36 - $3.87 |
|---|---|
| 52-Week High | $44.73 |
| 52-Week Low | $3.09 |
| Open | $3.76 |
| Volume (last close) | 38.39K |
| Average Volume (3M) | 119.60K |
| Revenue (TTM) | 15.62M |
|---|---|
| Net Income (TTM) | 6.90M |
| Free Cash Flow (TTM) | 2.25M |
| EPS (TTM) | $0.16 |
| Profit Margin | 44.20% |
| Operating Margin | 39.40% |
| Return on Equity (ROE) | 22.90% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 162.40M |
|---|---|
| Shares Outstanding | 43.89M |
| P/E Ratio (TTM) | 24.22 |
| Price to Sales (P/S) | 10.71 |
| Price to Book (P/B) | 5.55 |
| EV/EBITDA | 28.92 |
| 50-Day MA | $6.30 |
|---|---|
| 200-Day MA | $18.60 |
| 1-Year Change | −84.99% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Anbio Biotechnology at a Glance
As of the Oct 26, 2026 close, Anbio Biotechnology (NNNN) has a market capitalization of $162.40M. The stock trades at 24.2× trailing earnings and 10.7× sales. Over the trailing twelve months it earned $6.90M on revenue of $15.62M (a 44.2% profit margin) and generated $2.25M of free cash flow. Revenue grew 5.6% year over year.
As of its latest reported balance sheet, it holds $7.77M in cash and securities against $0.00 of debt, a net cash position of $7.77M.
Anbio Biotechnology does not currently pay a dividend.
The share price is down 85.0% over the past year. At $3.70 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $3.09 to $44.73, below its 200-day moving average of $18.60.
Frequently Asked Questions About Anbio Biotechnology
What is the current stock price for NNNN?
As of the Oct 26, 2026 close, NNNN stock trades at $3.70. The 52-week range is $3.09–$44.73, with a day range of $3.36–$3.87.
What is the P/E ratio for NNNN?
As of the Oct 26, 2026 close, Anbio Biotechnology's trailing twelve-month (TTM) P/E ratio is 24.2, meaning investors pay $24.2 for every $1 of annual earnings. Anbio Biotechnology operates in the Healthcare sector.
Does NNNN pay dividends?
Anbio Biotechnology does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for NNNN?
Analyst ratings and recommendations for NNNN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NNNN?
As of the Oct 26, 2026 close, Anbio Biotechnology's market capitalization is $162.4M, classifying it as a micro-cap company. Anbio Biotechnology operates in the Healthcare sector within the Medical Instruments & Supplies industry.